Article
Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders
22 Feb 2018
Abstract excerpt
INTRODUCTION: Major depressive disorder (MDD) and bipolar disorder (BD) are leading causes of disability worldwide, yet many people remain undiagnosed, are misdiagnosed, and/or ineffectively treated. Diagnosis relies on the clinical assessment of symptoms, and there is currently no molecular or brain-imaging diagnostic test available. Identifying and validating protein biomarkers could provide a more accurate and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
